Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 2.38 is 71% below its 5-year average of 8.08, near the low end of its 5-year range (2.38–17.08).
As of the fiscal period ended Tuesday, June 30, 2026. 30.28% below its 12-month average of 3.41.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.38.
QUICK RATIO (ACID-TEST)
2.38
QUICK RATIO (ACID-TEST) AVG TTM
3.41
QUICK RATIO (ACID-TEST) AVG 3Y
5.03
QUICK RATIO (ACID-TEST) AVG 5Y
8.08
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-30.28%
CURRENT VS 3Y AVG
-52.71%
CURRENT VS 5Y AVG
-70.52%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 581 covered companies
CURRENT VS SECTOR MEDIAN
-20.39%
vs the sector median at left
908 Devices Inc.
Market Cap
$513.25M
Quick Ratio (Acid-Test)
2.38
TTM Avg
3.41
3Y Avg
5.03
5Y Avg
8.08
Market Cap
$507.55M
Quick Ratio (Acid-Test)
33.56
TTM Avg
31.41
3Y Avg
17.80
5Y Avg
16.41
Market Cap
$516.46M
Quick Ratio (Acid-Test)
26.78
TTM Avg
15.83
3Y Avg
15.06
5Y Avg
15.09
Market Cap
$521.76M
Quick Ratio (Acid-Test)
25.13
TTM Avg
6.17
3Y Avg
7.34
5Y Avg
19.91
Market Cap
$498.75M
Quick Ratio (Acid-Test)
10.72
TTM Avg
8.23
3Y Avg
9.67
5Y Avg
9.58
Market Cap
$531.34M
Quick Ratio (Acid-Test)
9.66
TTM Avg
5.09
3Y Avg
5.58
5Y Avg
6.85
Market Cap
$533.01M
Quick Ratio (Acid-Test)
8.95
TTM Avg
10.43
3Y Avg
5.97
5Y Avg
5.34
Market Cap
$551.88M
Quick Ratio (Acid-Test)
9.36
TTM Avg
2.17
3Y Avg
1.76
5Y Avg
2.63
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| 908 Devices Inc. (MASS) | $513.25M | 2.38 | 3.41 | 5.03 | 8.08 |
| Monopar Therapeutics Inc. (MNPR)vs › | $507.55M | 33.56 | 31.41 | 17.80 | 16.41 |
| Altimmune, Inc. (ALT)vs › | $516.46M | 26.78 | 15.83 | 15.06 | 15.09 |
| Immix Biopharma, Inc. (IMMX)vs › | $521.76M | 25.13 | 6.17 | 7.34 | 19.91 |
| Allogene Therapeutics, Inc. (ALLO)vs › | $498.75M | 10.72 | 8.23 | 9.67 | 9.58 |
| Crescent Biopharma, Inc. (CBIO)vs › | $531.34M | 9.66 | 5.09 | 5.58 | 6.85 |
| Delcath Systems, Inc. (DCTH)vs › | $533.01M | 8.95 | 10.43 | 5.97 | 5.34 |
| CytomX Therapeutics, Inc. (CTMX)vs › | $551.88M | 9.36 | 2.17 | 1.76 | 2.63 |
| Evolus, Inc. (EOLS)vs › | $473.57M | 1.28 | 1.88 | 1.90 | 1.89 |
| Bright Minds Biosciences Inc. (DRUG)vs › | $473.36M | 121.97 | 23.71 | 19.95 | 19.50 |
Quick Ratio
2.38
Excludes inventory
Current Ratio
2.67
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 2.38 |
| 2026-03-31 | 3.25 |
| 2025-12-31 | 3.86 |
| 2025-09-30 | 3.12 |
| 2025-06-30 | 4.46 |
| 2025-03-31 | 6.97 |
| 2024-12-31 | 3.45 |
| 2024-09-30 | 3.54 |
| 2024-06-30 | 4.23 |
| 2024-03-31 | 7.53 |
| 2023-12-31 | 7.04 |
| 2023-09-30 | 7.34 |
| 2023-06-30 | 8.27 |
| 2023-03-31 | 9.36 |
| 2022-12-31 | 10.56 |
| 2022-09-30 | 11.12 |
| 2022-06-30 | 14.74 |
| 2022-03-31 | 17.08 |
| 2021-12-31 | 16.51 |
| 2021-09-30 | 11.42 |
| 2021-06-30 | 13.35 |
| 2021-03-31 | 16.89 |
| 2020-12-31 | 15.36 |
| 2020-09-30 | 2.40 |
| 2020-06-30 | 3.18 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 3.86 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
